145 related articles for article (PubMed ID: 26510431)
1. Nutritional and therapeutic approaches to modulate NADPH oxidase-derived ROS signaling in platelets.
Violi F; Pastori D; Carnevale R; Pignatelli P
Curr Pharm Des; 2015; 21(41):5945-50. PubMed ID: 26510431
[TBL] [Abstract][Full Text] [Related]
2. Statins as regulators of redox signaling in platelets.
Violi F; Pignatelli P
Antioxid Redox Signal; 2014 Mar; 20(8):1300-12. PubMed ID: 23992095
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant and antiplatelet effects of atorvastatin by Nox2 inhibition.
Violi F; Carnevale R; Pastori D; Pignatelli P
Trends Cardiovasc Med; 2014 May; 24(4):142-8. PubMed ID: 24263084
[TBL] [Abstract][Full Text] [Related]
4. Platelet oxidative stress and thrombosis.
Violi F; Pignatelli P
Thromb Res; 2012 Mar; 129(3):378-81. PubMed ID: 22209450
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase 2 (NOX2): A key target of oxidative stress-mediated platelet activation and thrombosis.
Fuentes E; Gibbins JM; Holbrook LM; Palomo I
Trends Cardiovasc Med; 2018 Oct; 28(7):429-434. PubMed ID: 29661712
[TBL] [Abstract][Full Text] [Related]
6. Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers.
Carnevale R; Loffredo L; Pignatelli P; Nocella C; Bartimoccia S; Di Santo S; Martino F; Catasca E; Perri L; Violi F
J Thromb Haemost; 2012 Jan; 10(1):125-32. PubMed ID: 22066819
[TBL] [Abstract][Full Text] [Related]
7. Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis.
Delaney MK; Kim K; Estevez B; Xu Z; Stojanovic-Terpo A; Shen B; Ushio-Fukai M; Cho J; Du X
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):846-54. PubMed ID: 26988594
[TBL] [Abstract][Full Text] [Related]
8. NADPH Oxidase-2 and Atherothrombosis: Insight From Chronic Granulomatous Disease.
Violi F; Carnevale R; Loffredo L; Pignatelli P; Gallin JI
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):218-225. PubMed ID: 27932349
[TBL] [Abstract][Full Text] [Related]
9. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway.
Begonja AJ; Gambaryan S; Geiger J; Aktas B; Pozgajova M; Nieswandt B; Walter U
Blood; 2005 Oct; 106(8):2757-60. PubMed ID: 15976180
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation.
Pignatelli P; Carnevale R; Di Santo S; Bartimoccia S; Nocella C; Vicario T; Loffredo L; Angelico F; Violi F
Biochem Pharmacol; 2012 Dec; 84(12):1635-42. PubMed ID: 23022230
[TBL] [Abstract][Full Text] [Related]
11. The anti-platelet effects of apocynin in mice are not mediated by inhibition of NADPH oxidase activity.
Dharmarajah J; Arthur JF; Sobey CG; Drummond GR
Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):377-84. PubMed ID: 20809239
[TBL] [Abstract][Full Text] [Related]
12. Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell.
Morotti A; Barale C; Melchionda E; Russo I
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232746
[TBL] [Abstract][Full Text] [Related]
13. Redox regulation of platelet function and thrombosis.
Jiang H; Nechipurenko DY; Panteleev MA; Xu K; Qiao J
J Thromb Haemost; 2024 Jun; 22(6):1550-1557. PubMed ID: 38460839
[TBL] [Abstract][Full Text] [Related]
14. NADPH-oxidase-derived ROS alters cell migration by modulating adhesions dynamics.
Tamborindeguy MT; Matte BF; Ramos GO; Alves AM; Bernardi L; Lamers ML
Biol Cell; 2018 Oct; 110(10):225-236. PubMed ID: 30157294
[TBL] [Abstract][Full Text] [Related]
15. Current status of NADPH oxidase research in cardiovascular pharmacology.
Rodiño-Janeiro BK; Paradela-Dobarro B; Castiñeiras-Landeira MI; Raposeiras-Roubín S; González-Juanatey JR; Alvarez E
Vasc Health Risk Manag; 2013; 9():401-28. PubMed ID: 23983473
[TBL] [Abstract][Full Text] [Related]
16. Glucose impairs aspirin inhibition in platelets through a NAD(P)H oxidase signaling pathway.
Kobzar G; Mardla V; Samel N
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():33-40. PubMed ID: 28760712
[TBL] [Abstract][Full Text] [Related]
17. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
Sharma N; Nehru B
Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
[TBL] [Abstract][Full Text] [Related]
18. Soyasaponin Bb inhibits the recruitment of toll-like receptor 4 (TLR4) into lipid rafts and its signaling pathway by suppressing the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent generation of reactive oxygen species.
Zhang Y; Chen F; Chen J; Huang S; Chen J; Huang J; Li N; Sun S; Chu X; Zha L
Mol Nutr Food Res; 2016 Jul; 60(7):1532-43. PubMed ID: 27005845
[TBL] [Abstract][Full Text] [Related]
19. NADPH Oxidase-Derived ROS Signaling and Therapeutic Opportunities.
Peshavariya H
Curr Pharm Des; 2015; 21(41):5931-2. PubMed ID: 26537745
[No Abstract] [Full Text] [Related]
20. Functional role of NADPH oxidase in activation of platelets.
Chlopicki S; Olszanecki R; Janiszewski M; Laurindo FR; Panz T; Miedzobrodzki J
Antioxid Redox Signal; 2004 Aug; 6(4):691-8. PubMed ID: 15242549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
